Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Balance Sheet
Balance Sheet Decomposition
Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd
Balance Sheet
Krishna Institute of Medical Sciences Ltd
| Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
32
|
83
|
110
|
81
|
405
|
521
|
256
|
616
|
469
|
560
|
|
| Cash |
32
|
83
|
110
|
81
|
325
|
321
|
256
|
607
|
311
|
493
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
80
|
200
|
0
|
9
|
158
|
67
|
|
| Short-Term Investments |
0
|
0
|
4
|
21
|
52
|
2 323
|
1 644
|
726
|
851
|
457
|
|
| Total Receivables |
945
|
1 301
|
1 160
|
1 358
|
1 427
|
1 296
|
1 581
|
2 910
|
3 308
|
4 874
|
|
| Accounts Receivables |
728
|
984
|
1 138
|
1 308
|
1 370
|
1 255
|
1 565
|
2 829
|
3 206
|
4 348
|
|
| Other Receivables |
216
|
317
|
22
|
51
|
57
|
41
|
16
|
81
|
101
|
526
|
|
| Inventory |
123
|
164
|
201
|
269
|
304
|
266
|
431
|
480
|
722
|
892
|
|
| Other Current Assets |
50
|
10
|
84
|
9
|
10
|
106
|
22
|
45
|
125
|
190
|
|
| Total Current Assets |
1 150
|
1 558
|
1 560
|
1 739
|
2 198
|
4 512
|
3 934
|
4 776
|
5 474
|
6 973
|
|
| PP&E Net |
5 152
|
5 800
|
7 094
|
7 638
|
8 072
|
8 308
|
9 094
|
18 575
|
26 613
|
41 560
|
|
| PP&E Gross |
5 152
|
5 800
|
7 094
|
7 638
|
8 072
|
8 308
|
9 094
|
18 575
|
26 613
|
41 560
|
|
| Accumulated Depreciation |
1 642
|
1 984
|
719
|
1 214
|
1 817
|
2 398
|
3 115
|
4 022
|
5 171
|
6 389
|
|
| Intangible Assets |
13
|
15
|
13
|
264
|
262
|
247
|
318
|
777
|
646
|
677
|
|
| Goodwill |
4
|
4
|
441
|
752
|
848
|
848
|
848
|
3 080
|
3 080
|
3 386
|
|
| Note Receivable |
0
|
83
|
284
|
403
|
387
|
187
|
1 106
|
1 214
|
1 277
|
2 711
|
|
| Long-Term Investments |
109
|
143
|
10
|
8
|
1
|
26
|
3 337
|
61
|
745
|
771
|
|
| Other Long-Term Assets |
107
|
143
|
179
|
393
|
191
|
234
|
437
|
929
|
683
|
1 282
|
|
| Other Assets |
4
|
4
|
441
|
752
|
848
|
848
|
848
|
3 080
|
3 080
|
3 386
|
|
| Total Assets |
6 657
N/A
|
7 746
+16%
|
9 580
+24%
|
11 197
+17%
|
11 959
+7%
|
14 362
+20%
|
19 073
+33%
|
29 413
+54%
|
38 520
+31%
|
57 360
+49%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
668
|
784
|
950
|
1 041
|
1 234
|
1 319
|
1 295
|
1 743
|
1 972
|
2 691
|
|
| Accrued Liabilities |
114
|
129
|
177
|
216
|
189
|
218
|
251
|
304
|
400
|
472
|
|
| Short-Term Debt |
171
|
117
|
305
|
176
|
101
|
0
|
15
|
193
|
907
|
1 293
|
|
| Current Portion of Long-Term Debt |
648
|
716
|
4 285
|
306
|
444
|
884
|
287
|
253
|
383
|
1 402
|
|
| Other Current Liabilities |
136
|
160
|
1 776
|
270
|
220
|
363
|
302
|
473
|
861
|
2 504
|
|
| Total Current Liabilities |
1 736
|
1 906
|
7 494
|
2 009
|
2 188
|
2 783
|
2 150
|
2 965
|
4 523
|
8 362
|
|
| Long-Term Debt |
1 742
|
1 970
|
2 942
|
2 882
|
3 143
|
2 279
|
2 263
|
6 336
|
12 263
|
22 872
|
|
| Deferred Income Tax |
421
|
455
|
460
|
516
|
357
|
358
|
379
|
492
|
463
|
468
|
|
| Minority Interest |
68
|
74
|
202
|
263
|
133
|
125
|
233
|
2 684
|
2 649
|
2 810
|
|
| Other Liabilities |
56
|
77
|
66
|
121
|
157
|
179
|
174
|
241
|
339
|
1 470
|
|
| Total Liabilities |
4 024
N/A
|
4 482
+11%
|
11 165
+149%
|
5 791
-48%
|
5 978
+3%
|
5 724
-4%
|
5 200
-9%
|
12 718
+145%
|
20 237
+59%
|
35 982
+78%
|
|
| Equity | |||||||||||
| Common Stock |
704
|
716
|
502
|
745
|
745
|
776
|
800
|
800
|
800
|
800
|
|
| Retained Earnings |
1 443
|
1 768
|
2 379
|
2 864
|
2 289
|
587
|
2 732
|
5 555
|
7 143
|
10 238
|
|
| Additional Paid In Capital |
487
|
780
|
293
|
7 526
|
7 526
|
8 448
|
10 340
|
10 340
|
10 340
|
10 340
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2 634
N/A
|
3 264
+24%
|
1 584
N/A
|
5 407
N/A
|
5 981
+11%
|
8 637
+44%
|
13 873
+61%
|
16 695
+20%
|
18 284
+10%
|
21 378
+17%
|
|
| Total Liabilities & Equity |
6 657
N/A
|
7 746
+16%
|
9 580
+24%
|
11 197
+17%
|
11 959
+7%
|
14 362
+20%
|
19 073
+33%
|
29 413
+54%
|
38 520
+31%
|
57 360
+49%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
80
|
80
|
80
|
80
|
80
|
80
|
400
|
400
|
400
|
400
|
|